References
- Sajjadi H, Paparella MM. Meniere's disease. Lancet. 2008; 372(9636):406–414.
- Watanabe Y, Shojaku H, Junicho M, et al. Intermittent pressure therapy of intractable Meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report. Acta Otolaryngol. 2011;131(11):1178–1186.
- Schuknecht HF. Delayed endolymphatic hydrops. Ann Otol Rhinol Laryngol. 1978; 87(6 Pt 1):743–748.
- Feldmann H. Tympanic membrane massage, origin and decline of a promising therapeutic concept. Laryngorhinootologie. 1996; 75(8):491–498.
- Watanabe I. Ménière's disease with special emphasis on epidemiology, diagnosis and prognosis. ORL J Otorhinolaryngol Relat Spec. 1980; 42(1-2):20–45.
- Komatsuzaki A, Futaki T, Harada Y, et al. Delayed endolymphatic hydrops. Equilibrium Res. 1987;47(11):33–34.
- Gates GA, Green JD, Jr, Tucci DL, et al. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease. Arch Otolaryngol Head Neck Surg. 2004;130(6):718–725.
- Gürkov R, Filipe Mingas LB, Rader T, et al. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial. J Laryngol Otol. 2012; 126(4):356–362.
- Mizukoshi K, Watanabe Y, Shojaku H, et al. Preliminary guidelines for reporting treatment results in Menière's disease conducted by the Committee of the Japanese Society for Equilibrium Research, 1993. Acta Otolaryngol Suppl. 1995;519:211–215.
- Odkvist LM, Arlinger S, Billermark E, et al. Effects of middle ear pressure changes on clinical symptoms in patients with Meniere's disease – a clinical multicentre placebo-controlled study. Acta Otolaryngol Suppl. 2000; 543:99–101.
- Russo FY, Nguyen Y, De Seta D, et al. Meniett device in Meniere disease: Randomized, double-blind, placebo-controlled multicenter trial. Laryngoscope. 2017; 127(2):470–475.
- Thomsen J, Sass K, Odkvist L, et al. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol. 2005; 26(1):68–73.
- Wang SJ, Yang H, Yao YY, Hubei University of Medicine, Taihe Hospital, Center for Evidence-Based Medicine and Clinical Research, Shiyan, China, et al. The clinical benefit of device therapy for Meniere's disease in adults: systematic review and meta-analysis. Int Adv Otol. 2019;15(1):121–129.
- Shojaku H, Watanabe Y, Mineta H, et al. Long-term effects of the Meniett device in Japanese patients with Meniere's disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan. Acta Otolaryngol. 2011; 131(3):277–283.
- Montandon P, Guillemin P, Hausler R. Prevention of vertigo in Ménière's syndrome by means of transtympanic ventilation tubes. ORL J Otorhinolaryngol Relat Spec. 1988; 50(6):377–381.
- Barbara M, Monini S, Chiappini I, et al. Meniett therapy may avoid vestibular neurectomy in disabling Meniere's disease. Acta Otolaryngol. 2007; 127(11):1136–1141.
- Iwasaki S, Shojaku H, Murofushi T, Committee for Clinical Practice Guidelines of Japan Society for Equilibrium Research, et al. Diagnostic and therapeutic strategies for Meniere's disease of the Japan Society for Equilibrium Research. Auris Nasus Larynx. 2021;48(1):15–22.